What's new

Summerour, Jenny
November 2002
Progressive Grocer;11/15/2002, Vol. 81 Issue 17, p74
Trade Publication
Presents several new products in the U.S. as of December 2002. Excedrin QuickTabs analgesic from Bristol-Myers Squibb Co.; Herbal Clear Naturally! deodorant; Almond Toppers from Fresh Gourmet.


Related Articles

  • Excedrin bangs Tylenol. Winters, Patricia; Freeman, Laurie // Advertising Age;8/13/1990, Vol. 61 Issue 33, p3 

    This article reports on the introduction of the Aspirin Free Excedrin product by Bristol-Myers Squibb Co. in 1990. The company will launch a television advertising campaign for the product. Bristol-Myers claims that the drug is better than the Extra-Strength Tylenol product of McNeil Consumer...

  • Ban renews title for Naismaith Basketball Awards.  // Brandweek;11/28/94, Vol. 35 Issue 46, p5 

    Reports on the renewal of Bristol-Meyers college basketball sponsorship of the Naismith Awards with Ban deodorant as title sponsor. Plans for the advertising of Ban for Men during college games and in sports magazine.

  • Bristol claims clear difference in roll-ons. Weisz, Pam // Brandweek;2/20/95, Vol. 36 Issue 8, p5 

    Reports on the Bristol-Myers' plan to revitalize the roll-on deodorant category and its leading line in the segment. Bristol-Myers' market share in the deodorant category; Projections for segment growth in 1995; Television advertising slated for its product Ban; Launching of the Ban Clear...

  • Excedrin extra strength gets prelim nod for migraines.  // Brandweek;07/21/97, Vol. 38 Issue 29, p29 

    Focuses on the Bristol-Myers Squibb company obtaining initial authorization from the government to market its Excedrin Extra Strength pain reliever. Details on the United States Drug and Administration expected acceptance of the authorization; Information on the federal advisory panel;...

  • Condition-specific treatment trend drives growth in pain relief segment. Johnsen, Michael // Drug Store News;10/20/2003, Vol. 25 Issue 14, p23 

    Reports on the sales performance of the analgesics industry in the U.S. Growth of the sector; Launch of the Excedrin Tension Headache formulation from Bristol-Myers Squibb Co.; Incidence of pain conditions in the country.

  • Comarketing agreement.  // Drug Topics;8/22/94, Vol. 138 Issue 16, p23 

    Reports on an agreement between Bristol-Myers Squibb and Cephalon Inc. for the promotion of the analgesic Stadol NS (butorphanol tartrate).

  • Planned Excedrin launch gives Bristol-Myers Squibb headaches. Johnsen, Michael // Drug Store News;2/18/2002, Vol. 24 Issue 2, p27 

    Reports on the problems associated with the launching of a melt-in-your-mouth line extension of Excedrin analgesics manufactured by Bristol-Myers Squibb. Supply disruption related to one of the product's ingredients; Price range of the product.

  • Bristol pops up in surging antacid market. Winters, Patricia // Advertising Age;10/1/1990, Vol. 61 Issue 41, p3 

    The article reports on Bristol-Myers Squibb Co.'s foray into the antacid market with its Medacid brand, claimed to be superior to others because of its caplet form. The product is undergoing testing in the West Coast and could be launched nationally in a year. A Bristol-Myers spokeswoman claimed...

  • Clairol backs Daily Defense shampoo with $40 mil push. Sloan, Pat; Wilke, Michael // Advertising Age;6/23/1997, Vol. 68 Issue 25, p3 

    The article reports on Bristol-Myers Squibb Co.'s Clairol unit's launch of their Daily Defense shampoo and conditioner products in the United States. The shampoo features a chelating agent which coats and protects the hair from damage. The initial advertising work has been assigned to Wells Rich...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics